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Improving micronutrient intakes of under‐nourished mothers in low‐ and middle‐income countries
increases birth weight, but there is little data on the nature and timing during gestation of any effects
on fetal growth. Ultrasound measures of fetal size were used to determine whether and when a
food‐based supplement affected fetal growth. Non‐pregnant women living in Mumbai slums, India
(N = 6,513), were randomly assigned to receive either a daily micronutrient‐rich snack containing
green leafy vegetables, fruit, and milk (treatment) or a snack made from lower‐micronutrient vegeta-
bles (control) in addition to their usual diet from before pregnancy until delivery. From 2,291 preg-
nancies, the analysis sample comprised 1,677 fetuses (1,335 fetuses of women supplemented for
≥3 months before conception). First‐trimester (median: 10 weeks, interquartile range: 9–12 weeks)
fetal crown‐rump length was measured. Fetal head circumference, biparietal diameter, femur length,
and abdominal circumference weremeasured during the second (19, 19–20weeks) and third trimes-
ters (29, 28–30 weeks). The intervention had no effect on fetal size or growth at any stage of
pregnancy. In the second trimester, there were interactions between parity and allocation group
for biparietal diameter (p = .02) and femur length (p = .04) with both being smaller among fetuses
of primiparous women and larger among those of multiparous women, in the treatment group
compared with the controls. Overall, a micronutrient‐rich supplement did not increase standard
ultrasound measures of fetal size and growth at any stage of pregnancy. Additional ultrasound
measures of fetal soft tissues (fat and muscle) may be informative.
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Low birth weight (LBW) is an important public health problem in low‐
andmiddle‐income countries (UNICEF &WHO, 2004). LBW commonly
results from intrauterine growth restriction and is associated with
increased neonatal mortality and morbidity, slower postnatal growth,
poorer cognitive development, and a higher risk of chronic non‐
communicable diseases in later life (Barker, 1998; Victora et al., 2008).e Creative Commons Attribution Li
blished by John Wiley & Sons Ltd
wileyonlPoor maternal nutritional status contributes to the prevalence of
LBW (Osrin & De L Costello, 2000). Many studies have investigated the
effect on birth outcomes of supplementing mothers with multiple
micronutrients during pregnancy (Haider & Bhutta, 2015; Kawai,
Spiegelman, Shankar, & Fawzi, 2011). Meta‐analyses suggest that this
reduces the prevalence of LBW (Fall, Fisher, Osmond, & Margetts,
2009; Shah, Ohlsson, & Knowledge Synthesis Group on Determinants
of Low Birth Weight and Preterm Births, 2009). An observational studycense, which permits use, distribution and reproduction in any medium, provided
inelibrary.com/journal/mcn 1 of 12
Key messages
• In this study, a food‐based micronutrient‐rich
supplement had no overall effect on standard
ultrasound measures of fetal size or growth.
• In a subgroup analysis the intervention may have
increased growth in fetal biparietal diameter and femur
length up to 20 weeks among multiparous mothers,
and reduced it among primiparous mothers.
• To understand nutritional effects on fetal growth,
additional ultrasound measures of fetal soft tissue
(adipose tissue and muscle) might be informative.
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the frequency of consumption by the mother of milk in early gesta-
tion, and of green leafy vegetables and fruit in late gestation, with
the latter associations being stronger in lighter and thinner women
(Rao et al., 2001).
The Pune results led to a randomised controlled trial, the Mumbai
Maternal Nutrition Project (MMNP), to test whether supplementing
the mother’s diet with green leafy vegetables, milk, and fruit reduces
LBW. Recent evidence indicates that processes occurring in early ges-
tation, such as de‐ and re‐methylation of fetal DNA, the development
of the placenta, and fetal organogenesis are important determinants of
not only size at birth but also long‐term health (Cetin, Berti, &
Calabrese, 2010; Oliver, Jaquiery, Bloomfield, & Harding, 2007;
Watkins & Fleming, 2009). MMNP therefore aimed to enhance mater-
nal nutritional status for a sustained period of time (chosen a priori to
be at least 3 months) before conception as well as throughout preg-
nancy. Low‐income non‐pregnant women in Mumbai, who intended
to have children, were randomly assigned to receive either a daily
micronutrient‐rich snack containing green leafy vegetables, fruit, and
milk or a lower‐micronutrient snack, in addition to their usual diet from
before pregnancy until delivery (Potdar et al., 2014). There was no
overall effect of the intervention on birth weight in the intention to
treat analysis but a positive effect in the per protocol analysis limited
to women supplemented for at least 3 months before conception. In
both analyses, there was an interaction between allocation group and
maternal pre‐pregnancy body mass index (BMI) such that, while there
was no intervention effect in underweight women (BMI ≤18.5 kg/m2),
there was a positive effect on birth weight among mothers of normal
or high BMI.
Birth weight is not an optimal proxy for fetal growth, because
two babies with the same birth weight and size may achieve this
by different growth trajectories (Wills, Yajnik, & Kinare, 2010). We
used ultrasound measures of fetal size in the MMNP to (a) determine
whether supplementation influenced fetal size and growth and (b)
determine the timing during pregnancy of any effect. We
hypothesised that fetal measurements would be increased in the
treatment group, that differences would be present from early
pregnancy, and that effects would increase with maternal pre‐
pregnancy BMI.2 | METHODS
2.1 | Study population
Enrolment into the MMNP took place between 2006 and 2012 in slum
areas of Mumbai, India, covered by the health and social programs of
the non‐governmental organization the Centre for the Study of Social
Change. Women were eligible if aged <40 years, married, non‐
pregnant, not sterilised, planning to have children and intending
to deliver in Mumbai. Six thousand five hundred thirteen women
were recruited and randomly assigned to receive either a daily micro-
nutrient‐rich snack containing green leafy vegetables, fruit, and milk
(treatment group) or a snack made from lower‐micronutrient vege-
tables such as onion and potato (controls), in addition to theirusual diet, from before pregnancy until delivery. Random assign-
ment was generated remotely in Southampton, United Kingdom.
Women were individually randomly assigned, after stratifying by
age and BMI.
To optimise the content and palatability of the supplements we
carried out extensive pilot work before starting the trial
(Shivashankaran et al., 2011). The most acceptable way of delivering
the foods was in the form of a snack that resembled local street food
(e.g., samosas and fritters). Treatment snacks contained fresh or dried
green leafy vegetables, full‐fat milk powder, and fruit powder or dried
fruit (Table S1). Multiple recipes were tested for palatability prior to
the trial, and we continued to develop new recipes throughout the
trial to reduce monotony and in response to the women’s comments,
with only small changes in micronutrient content; on average, treat-
ment snacks contained 10%–23% of the WHO/FAO recommended
Reference Nutrient Intake for β‐carotene, riboflavin, folate,
vitamin B12, calcium, and iron compared with <10% in control snacks
(Table S2). Further information on the randomization procedure and
snacks can be found elsewhere (Potdar et al., 2014).2.2 | Data collection
Health workers made home visits to explain the trial, and community
meetings were held to answer questions and obtain consent.
Women were invited to attend recruitment clinics, at which they
were screened for eligibility and individual written consent was
obtained. At recruitment, women were asked about their occupation,
education, religion, parity, and use of tobacco (in both smoked and
chewed form). Socio‐economic status was assessed using the stan-
dard of living index, a widely used questionnaire‐based method
developed for national surveys, based on housing type, utilities,
and household possessions (International Institute for Population Sci-
ences, 2001). A higher score represents higher socio‐economic sta-
tus. Diet was assessed at recruitment and in the second trimester
of pregnancy using a quantified food frequency questionnaire
(Chopra et al., 2012) with a reference period of the preceding week.
Weight and height were measured using standardised in‐house pro-
tocols. Height was measured to the nearest 0.1 cm using a portable
LAWANDE ET AL. 3 of 12bs_bs_bannerHarpenden stadiometer (CMS Instruments Ltd. London) with the
head positioned in the Frankfort plane. Weight was measured to
the nearest 0.5 kg after removing heavy items of clothing and
jewellery.
To ensure that women would not have to walk further than
300–500 m from home to obtain their snacks, 61 supplementation
centres were set up in the study area. Women were given one snack
a day, and consumption was observed and recorded. Women were
deemed compliant if they consumed, on average, at least half the avail-
able snacks in a given week. Staff at the supplementation centres
maintained a record of the women’s last menstrual period (LMP) dates,
and updated this every month.
Women who missed two periods had a urinary pregnancy test, and
if this was positive, they were invited to a central clinic at Centre for
the Study of Social Change at 9–12 weeks gestation for an obstetric
assessment and ultrasonography to confirm the pregnancy and mea-
sure fetal size. Further ultrasound scans were scheduled for 19–21
and 28–32 weeks gestation. For the purpose of this study, in which
we wanted to detect differences in fetal size, even in early stages of
pregnancy, we based gestational age on LMP date rather than ultra-
sound measurements (Wills et al., 2010).
Fetal biometry was measured using a Siemens Sonoline ADARA
ultrasound machine with a 4‐MHz probe. At visit 1, crown‐rump length
(CRL) was measured. However, if women attended late and the gesta-
tional age at the first examination was ≥13 weeks, fetal head circum-
ference (HC), biparietal diameter (BPD), femur length (FL), and
abdominal circumference (AC) were recorded instead. HC, BPD, FL,
and AC were assessed at the two subsequent visits. Measurements
were performed using standard techniques (Hadlock, 1990). HC was
calculated using the longest and shortest axes of the fetal head, mea-
sured from the outer to outer surfaces of the skull. BPD was measured
from outer to inner surfaces of the skull. FL was measured along the
long axis of the femur without the distal femoral epiphysis. AC was
estimated using the anteroposterior and the transverse diameters
(Hadlock, 1990); after ensuring that the stomach bubble was visible,
the abdomen filled at least 30% of the monitor screen and neither
the kidneys nor the bladder were visible, taking care not to cause dis-
tortion by exerting too much pressure with the probe (Papageorghiou
et al., 2014). At each examination, HC, BPD, and FL were measured
once. AC was measured once only if the fetus was optimally positioned
to obtain a perfect view (80% of the total scans); in the remaining
cases, AC was measured in triplicate and the average of the three mea-
sures was included in the analysis. Scans were carried out by a single
operator (AL) throughout the trial.
Trained research nurses measured newborns within 10 days of
birth. Measurements included weight (to the nearest 10 g, Seca scales)
and occipito‐frontal head circumference and abdominal circumference
immediately below the umbilicus, each measured thrice to the nearest
0.1 cm using fibreglass tapes and averaged.2.3 | Analysis sample
When we started the trial, pregnancies were followed up only if the
women started supplementation at least 3 months prior to their LMP
date. However, the exclusion of women who conceived within3 months of starting supplementation disappointed the women con-
cerned and threatened the community’s goodwill towards the project,
and so from December 2008, we followed up all pregnancies (Potdar
et al., 2014). This change in protocol led to the implementation of
two analyses: intention‐to‐treat (ITT) and per‐protocol (PP). The for-
mer included all pregnancies, whereas the latter was limited to women
supplemented for 3 months or more before their LMP date.
For this analysis, we excluded twins (n = 26), fetuses with major
congenital abnormalities (n = 12), and those with a missing maternal
LMP date (n = 69). We also excluded pregnancies in which the LMP‐
derived gestation differed by more than 2 weeks from the gestation
estimated from an early (<20 weeks) ultrasound scan (n = 197), because
the LMP date was likely to be inaccurate in these cases. Pregnant
womenwith no information on delivery outcome (n = 22) and newborns
with missing information on sex (n = 41) were also excluded; these were
usually women who went to the village for delivery and were lost to
follow‐up. In India, it is illegal to reveal the sex of the fetus during preg-
nancy, and so we had to exclude all pregnancies resulting in abortions,
terminations, stillbirths, and maternal deaths (n = 245) because of
unknown fetal sex. Two preterm babies (<37weeks of gestation) whose
gestational‐age‐adjusted fetal measures, at each scan, were >3 stan-
dard deviations (SDs) higher than the population mean were excluded
because, given their available fetal biometric parameters, their LMP
date was likely to be incorrect. The exclusion criteria reduced the initial
sample to 1,677 pregnancies in the ITT analysis and 1,335 pregnancies
in the PP analysis. Among those 90% (ITT analysis: 1,508; PP analysis:
1,197) had one or more ultrasound measures. The sample considered
in this study is summarised in Figure 1.
2.4 | ETHICS
The trial (ISRCTN62811278) was approved by the ethics committees
of BYL Nair and TN Medical College, Grant Medical College, and Sir
JJ Group of Hospitals, Mumbai, and Southampton and SW Local
Research Ethics Committees. An independent data‐monitoring
committee reviewed the data every 6 months for 2 years and then
annually. The trial protocol can be obtained from the corresponding
author.
2.5 | STATISTICAL METHODS
We examined the differences in baseline measurements between
women who had three scans and those who had two or fewer scans.
We calculated partial correlations among gestation‐adjusted fetal size
measures whilst controlling for sex and allocation group. We compared
fetal biometry with the INTERGROWTH‐21st standards
(Papageorghiou et al., 2014) by computing the z score of HC, FL, and
AC as
zscoreMMNP ¼MMNP observation−INTERGROWTH meanINTERGROWTH SD
in the second (14–27 weeks) and the third trimester (>27 weeks) of
pregnancy. We were not able to compare BPD in this way, because
it was measured differently in the two studies.
FIGURE 1 Flowchart of participants in the Mumbai Maternal Nutrition Project (MMNP). Shaded boxes indicate women who started
supplementation ≥3 months before their last menstrual period (LMP)
4 of 12 LAWANDE ET AL.bs_bs_banner
LAWANDE ET AL. 5 of 12bs_bs_bannerTo test the effect of the intervention on fetal size, we considered
each visit separately and used all available data at each visit. Because ges-
tational age at the time of each visit varied between women, and fetal
size differed between the sexes (Table S3 and Figure S1), within cohort
sex‐and‐gestation‐specific z scores were calculated using the Lambda‐
Mu‐Sigma (LMS) method (Cole & Green, 1992; Fenton & Sauve, 2007).
The effect of the intervention on fetal growth was analysed using mixed
effects regression models to take into account the correlation between
repeated observations in the same individual and the possibility of a non-
linear association between fetal biometry and gestational age.
Unadjusted comparisons of fetal measures between allocation
groups were made using t tests and Mann–Whitney U tests for nor-
mally and non‐normally distributed variables, respectively. Multiple
regression models were implemented to assess the effect of the inter-
vention on fetal size and growth. The presence of interactions
between allocation group and maternal pre‐pregnancy BMI, height
and age (continuous variables), parity (discrete variable), and sex
(binary variable) was evaluated. Interactions between allocation group
and second trimester intakes of green leafy vegetables, fruit, and milk
were considered when analysing the effect of the intervention on fetal
size at visit 3. The effect of adjusting for compliance was also exam-
ined; for this purpose, average compliance was calculated from
3 months prior to the LMP (or from recruitment if supplementation
<3 months) up to the visit of interest. Tobacco use was not included
in the final set of adjustors because only 206 (9%) of pregnant women
consumed tobacco (mostly in chewed form), and there were no associ-
ations between maternal tobacco use and fetal measurements.
Women’s occupation, education, and standard of living index score
were first included as possible confounders; however, as there were
no associations between those variables and fetal measures (results
not shown), we excluded them from the models presented in this
paper. Results were considered statistically significant when p < .05.
The analyses were performed using R V.3.2.2 (Rigby & Stasinopoulos,
2005) and Stata V.14 (Stata Corporation, College Station, TX).3 | RESULTS
Two thousand two hundred ninety‐one women (35%) became preg-
nant during the trial and were followed up. The median age at concep-
tion was 25 years (interquartile range: 22–28); 34% of women were
underweight (BMI < 18.5 kg/m2) while 9% were overweight (BMI
between 25 and 29.9 kg/m2) and 2% were obese (BMI ≥ 30 kg/m2).
The majority of women were not in paid work (79%), had completed
secondary education (88%), were Hindu (70%), and spoke either Mara-
thi or Gujarati as their first language (55%). Forty‐six percent of women
were primiparous. Baseline characteristics of women who became
pregnant are summarised in Table 1.
The median (interquartile range) gestational age at each examina-
tion was 10 (9–12), 19 (19–20) and 29 (28–30) weeks, respectively.
Of the fetuses included in the analysis (n = 1,677), 1,151 (treatment:
67%, control: 71%) had CRL measured at visit 1, 1,332 fetuses (treat-
ment: 74% control: 80%) were measured at visit 2 and 1,233 (treat-
ment: 73%, control: 75%) were measured at visit 3. One thousand
one hundred five (treatment: 47%, control: 49%) women had threescans recorded, 471 (treatment: 22%, control: 19%) had two, and
223 (treatment: 10%, control: 10%) had only a single scan. Baseline
characteristics were mostly similar between women with complete
data and those with one or more scan missing (Table S4); differences
were observed with respect to parity and occupation. Specifically,
women with one previous delivery had higher odds of having a full
set of scans when compared to primiparous women (OR: 1.47, 95%
CI [1.22, 1.78], p < .001), and nonworking women had lower odds than
women engaged in paid work outside the home (OR: 0.71, 95% CI
[0.58, 0.87], p = .001).
Partial correlation coefficients among gestation‐adjusted fetal and
newborn measures were positive and statistically significant (Table S5).
Hence, fetuses who were larger in early gestation tended to be larger
in the later stages of pregnancy and at birth. When compared to the
INTERGROWTH‐21st standards, fetal AC was significantly smaller in
both the second and third trimesters of pregnancy (−1.21SD and
−1.26SD, respectively), whereas HC (−0.03SD and 0.03SD,
respectively) and FL (0.31SD and 0.36SD, respectively) were more
comparable (Figure 2).
3.1 | Intention‐to‐treat analysis
In unadjusted analyses, there was no effect of the intervention on CRL
at visit 1 (treatment mean CRL: −0.02SD; control mean CRL: 0.02SD;
difference between means: 0.04SD, 95% CI [−0.08SD, 0.16SD];
p = .50) or on HC, BPD, FL, and AC at any of the visits separately
(Figure 3). There were no significant interactions between allocation
group and maternal pre‐pregnancy BMI, height, age, or fetal sex. At
visit 2, there were significant interactions between parity and alloca-
tion group for BPD (p = .02) and FL (p = .04). The intervention effect
on BPD and FL became more positive as parity increased (Figure 4).
Fetal BPD and FL were smaller among primiparous women and larger
among women with more than one previous delivery in the treatment
group than in the control group. The supplement had no significant
effect on growth of any of the fetal biometry measures considered
(Table 2). There were no interactions between allocation group and
maternal characteristics or fetal sex.
3.2 | Per‐protocol analysis
Findings were similar to the ITT analysis. Neither CRL at visit 1 (treat-
ment mean CRL: −0.03SD; control mean CRL: 0.02SD; difference
between means: 0.05SD, 95% CI [−0.09SD, 0.18SD]; p = .51) nor
HC, BPD, FL, and AC at subsequent visits (Figure 3) were significantly
different between allocation groups. As in the larger group of women,
there was a significant interaction between allocation group and parity
(Figure 4) for FL at visit 2 (p = .03); however, the interaction was not
significant for BPD. The intervention did not have a significant effect
on growth of HC, AC, and FL.
3.3 | Compliance
Throughout pregnancy, the percentage of compliant women was
higher in the control group than in the treatment group. In the ITT
analysis, 56% of women were compliant at visit 1 (treatment: 51%,
control: 61%), and 58% were compliant at visits 2 (treatment: 50%,
TABLE 1 Pre‐pregnant characteristics of the women who became pregnant and fetal measures, according to allocation group
Treatment (N = 1,106) Control (N = 1,185)
pMedian (IQR) or n (%) N Median (IQR) or n (%) N
Weight (kg) 45.4 (39.8–51.6) 1,105 46 (40.6–52) 1,185 .17
Height (cm)a 151 (5.6) 1,106 151 (5.4) 1,184 .66
BMI (kg/m2) 19.8 (17.8–22.5) 1,105 19.9 (17.9–22.5) 1,184 .15
Age (years)b 25 (22–28) 1,105 25 (22–28) 1,180 .02
Parity 1,106 1,185 .04
0 384 (34.7%) 350 (29.5%)
1 497 (44.9%) 564 (47.6%)
2+ 225 (20.3%) 271 (22.9%)
Religion 1,106 1,184 .64
Hindu 785 (71.0%) 827 (69.9%)
Muslim 285 (25.8%) 313 (26.4%)
Other 36 (3.25%) 44 (3.70%)
Education 1,105 1,184 .37
Primary 128 (11.6%) 116 (9.80%)
Secondary 920 (83.3%) 1,003 (84.7%)
Graduate 57 (5.16%) 65 (5.49%)
Social living index score 25 (21–29) 1,077 25 (21–29) 1,138 .98
Mothertongue 1,105 1,182
Marathi/Gujarati 614 (55.6%) 643 (54.4%)
Hindi/Punjabi/Bengali 401 (36.3%) 450 (38.1%)
Other 90 (8.14%) 89 (7.53%)
Occupation 1,106 1,185 .61
Unskilled/semi‐skilled 171 (15.5%) 198 (16.7%)
Skilled/self‐employed 29 (2.62%) 38 (3.21%)
Semi‐professional/professional 20 (1.81%) 25 (2.11%)
Not working 886 (80.1%) 924 (78.0%)
Frequencies of dietary intake
Milk and milk products (tea excluded) 1,106 1,185 .38
<1 time/week 557 (50.4%) 572 (48.3%)
1–6 times/week 388 (35.1%) 449 (37.9%)
≥7 times/week 161 (14.6%) 164 (13.8%)
GLV 1,106 1,185 .60
<1 time/week 266 (24.1%) 278 (23.5%)
1–6 times/week 880 (74.3%) 880 (74.3%)
≥7 times/week 32 (2.89%) 27 (2.28%)
Fruit 1,106 1,185 .48
<1 time/week 171 (15.5%) 204 (17.2%)
1–6 times/week 755 (68.3%) 800 (67.5%)
≥7 times/week 180 (16.3%) 181 (15.3%)
Fetal Measuresc,d
CRL (cm) 2.9 (2.5–3.3) 540 2.9 (2.5–3.3) 611 .67
HC (cm)
Visit 1 9.6 (9.1–10.2) 135 9.8 (9.1–10.4) 132 .25
Visit 2 16.9 (16.0–17.8) 640 16.9 (16.0–17.9) 689 .44
Visit 3 27.9 (27.0–28.7) 581 27.9 (27.0–28.8) 643 .98
BPD (cm)
Visit 1 2.6 (2.5–2.8) 135 2.6 (2.5–2.8) 136 .66
(Continues)
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TABLE 1 (Continued)
Treatment (N = 1,106) Control (N = 1,185)
pMedian (IQR) or n (%) N Median (IQR) or n (%) N
Visit 2 4.5 (4.4–4.9) 640 4.6 (4.4–4.9) 692 .31
Visit 3 7.6 (7.3–7.9) 585 7.6 (7.4–7.9) 648 .68
FL (cm)
Visit 1 1.3 (1.1–1.4) 102 1.3 (1.2–1.5) 109 .13
Visit 2 3.2 (2.9–3.4) 638 3.1 (2.9–3.4) 690 .52
Visit 3 5.7 (5.5–5.9) 585 5.7 (5.4–5.9) 642 .17
AC (cm)
Visit 1 7.6 (6.8–8.1) 110 7.6 (7.0–8.2) 114 .69
Visit 2 13.6 (12.8–14.6) 637 13.6 (12.8–14.5) 687 .43
Visit 3 23.8 (22.7–25.0) 583 23.9 (22.7–24.9) 645 .91
Birth measuresc,d
Birth weighta (g) 2,651 (375) 572 2,610 (394) 621 .25
HCa (cm) 33.2 (1.3) 562 33.2 (1.3) 681 .61
ACa (cm) 28.5 (2.2) 564 28.4 (2.1) 682 .54
Note. AC = abdominal circumference; BPD = biparietal diameter; CRL = crown‐rump length; FL = femur length; GLV = green leafy vegetables; HC = head
circumference; IQR = interquartile range.
aMean and standard deviation for normally distributed variable.
bAge at conception.
cValues adjusted for median gestational age (in weeks); includes only those pregnancies that satisfied the conditions imposed on the last menstrual period
date.
dSingleton pregnancy without congenital abnormalities and with known sex and gestational age. Include only those pregnancies that satisfied the condition
imposed on the last menstrual period date (LMP).
FIGURE 2 Head circumference, biparietal diameter, femur length, and abdominal circumference according to gestational age (weeks) in relation to
the 3rd, 10th, 50th, 90th, and 97th centiles from the INTERGROWTH‐21st standards. Biparietal diameter in our study was measured differently
from the INTERGROWTH‐21st project; hence, the value could not be formally compared with the provided international standards.
IG = INTERGROWTH
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FIGURE 3 Standardised regression coefficients β (and 95% confidence interval) for the effect of the intervention on HC, BPD, FL, and AC at visits
1, 2, and 3. Results are taken from the unadjusted analysis (differences are computed as treatment − control. A positive β indicates larger size in the
intervention group). Circles refer to the mean difference in fetal size between control and treatment groups in the intention‐to‐treat analysis.
Triangles represents the same values estimated in the per‐protocol analysis. AC = abdominal circumference; BPD = biparietal diameter;
FL = femur length; HC = head circumference; ITT = intention‐to‐treat; PP = per‐protocol
8 of 12 LAWANDE ET AL.bs_bs_bannercontrol: 64%) and 3 (treatment: 50%, control: 66%). The percentage of
compliant women decreased in the PP analysis (52%, 54%, and 55% at
visits 1, 2, and 3, respectively). Less than 50% of the women in the
treatment group (45%, 45%, and 47% at visits 1, 2, and 3, respectively)
and approximately 60% of women in the control group were compliant
(58%, 61%, and 62% in each of the three visits). Compliance had no sig-
nificant effect on fetal size and growth at any stage of pregnancy
(results not shown). Adding compliance to the regression models
described above did not change the significance or the direction of
the associations.4 | DISCUSSION
In a food‐based randomised controlled trial among Indian women living
in Mumbai slums, a daily micronutrient‐rich snack eaten
preconceptionally and throughout pregnancy had no effect on ultra-
sound measures of fetal size or growth. At visit 2 (19–21 weeks), BPD
and FL were significantly influenced by an interaction between alloca-
tion group and parity, with the supplement having a greater positive
effect in fetuses of multiparous women. Fetal measures were positively
correlated throughout gestation with the highest correlations observedbetween visits 2 (19–29 weeks) and 3 (28–32 weeks). At all stages of
pregnancy, fetal AC was smaller than the INTERGROWTH‐21st
international standard, while HC and FL were comparable.4.1 | Strengths and limitations
Strengths of the study were individual random assignment and super-
vised supplementation. Employing health workers from the community
maximised participation. Estimating gestational age using the LMP
date instead of by ultrasound enabled the detection of possible varia-
tions of fetal size in early pregnancy. The serial monitoring of men-
strual period dates as well as the additional inclusion criteria placed
on the LMP minimised the possibility of computing erroneous gesta-
tional ages. The timing of supplementation (3–6 pm) was chosen to
minimise interference with the women’s normal diet. Comparison of
the women’s food intakes before pregnancy and in the second trimes-
ter will be the topic of a separate manuscript. There were no differ-
ences in baseline or second trimester food intakes and no differences
in the changes in food intakes between baseline and second trimester,
between allocation groups (results not shown here).
There were several limitations of the study. In total, 34% of
women were lost to follow‐up; however, a detailed analysis showed
TABLE 2 Regression coefficients and 95% confidence intervals (CIs)
derived from mixed effect regression models analysing the effect of
allocation group on fetal growth variables in the intention‐to‐treat and
per‐protocol analyses. Models were adjusted for sex, gestational age
(GA), and GA2
Intention‐to‐treat analysis Per‐protocol analysis
Estimate (95% CI) p Estimate (95% CI) p
HC (cm) −0.06 (−0.15, 0.04) .27 −0.05 (−0.16, 0.05) .33
BPD (cm) −0.01 (−0.04, 0.02) .61 −0.01 (−0.05, 0.03) .65
AC (cm) 0.00 (−0.12, 0.11) .93 −0.01 (−0.13, 0.11) .88
FL (cm) 0.00 (−0.03, 0.03) .92 0.00 (−0.03, 0.03) .88
Note. All values are regression coefficients; 95% CIs are reported in paren-
theses. AC = abdominal circumference; BPD = biparietal diameter;
FL = femur length; HC = head circumference.
FIGURE 4 Effect of the intervention on BPD and FL at visit 2 according to maternal parity. Values are means; error bars indicate 95% confidence
intervals. Panels (a) and (b) refer to the results obtained in the intention‐to‐treat analysis. Panel (c) summarises the results from the per‐protocol
analysis (women who started supplementation ≥3 months before their last menstrual period date). The numbers in each figure summarise the mean
difference between treatment and control of the considered measure according to parity. BPD = biparietal diameter; FL = femur length
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dropped out were small and did not differ between allocation groups
(Potdar et al., 2014). Only 898 (39%) women had completed the data
for the ultrasound measures and the baby’s sex, and there were signif-
icant differences in occupation and parity between those with com-
plete and incomplete scan data. Missing data might have reduced the
accuracy of the estimate of the intervention effect. The scheduling of
the last scan at 28–32 weeks of gestation meant that we could not
fully assess possible effects of the supplement during the last trimester
of pregnancy. Repeat measures of CRL, HC, BPD, and FL were not col-
lected; thus, the available data might be subject to measurement error.
However, studies have shown a high degree of repeatability of CRL,
HC, BPD, and FL (Perni et al., 2004; Souka, Pilalis, Papastefanou,
Kassanons, & Kassanons, 2012) and stable variability throughoutgestation of z‐scores of these ultrasound measures (Sarris et al.,
2012). The most variable measurement (AC) was measured 3 times if
the radiologist did not have a perfect view.4.2 | Interpretation of the main findings
Fetal ultrasoundmeasures were analysed to understandwhether and at
what stage of pregnancy the supplement influenced fetal growth. We
have reported that the supplement increased birth weight and other
“soft tissue” measurement (skinfolds and abdominal, mid‐upper arm
and chest circumference) in the newborns of mothers supplemented
for ≥3 months before pregnancy but had no effect on “bony mea-
surements” (length and head circumference) (Potdar et al., 2014).
Independently of length of supplementation, the effects on birth
weight and soft tissue measurements were modified by maternal
pre‐pregnancy BMI (there were greater effects of the supplementa-
tion among women of normal or high BMI). In contrast, we were
unable to detect an effect on ultrasound measures of fetal size and
growth, and there was no evidence of an interaction between alloca-
tion group and BMI.
These differences between fetal and newborn findings may be
partially explained by the nature of the ultrasound measures. HC,
BPD, and FL are measures of bone size. AC, the only soft tissue mea-
sure available, is characterised by high variability and can be distorted
by the transducer, although care was taken to avoid this. To under-
stand whether improving maternal nutrition has a significant effect
on fetal growth, additional ultrasound measures of fetal soft tissues,
such as mid‐thigh muscle thickness and abdominal subcutaneous tis-
sue (O’Connor et al., 2013), may be informative. Fetal growth during
late gestation (>33 weeks) might also explain the differences in
10 of 12 LAWANDE ET AL.bs_bs_bannersupplement effects between fetal and birth measures (Bernstein,
Goran, Amini, & Catalano, 1997; Tanner, 1978). The sample in this
study was smaller than the one used to analyse the effect of the sup-
plement on birth weight; however, the differences observed between
fetal and newborn findings could not be explained by the available
sample size as we still found an effect of the supplement on
birthweight and an interaction between allocation group and maternal
pre‐pregnancy BMI in this study sample (results not shown).
Numerous trials have examined the effect of multiple micronutri-
ent supplementation during pregnancy on birth outcomes (Brough,
Rees, Crawford, Morton, & Dorman, 2010; Osrin et al., 2005; Zagré,
Desplats, Adou, Mamadoultaibou, & Aguayo, 2007), but literature on
the effect of supplementation on fetal biometry is scarce. A
randomised controlled trial in The Gambia showed that a prenatal
lipid‐based nutritional supplement had no effect on fetal growth
overall, but that fetal measurements at 30‐week gestation were
larger in the dry season among women receiving protein and energy
compared with those receiving multiple micronutrients alone or with
protein and energy and multiple micronutrients combined (Johnson
et al., 2016). A trial in Peru showed a positive effect of prenatal zinc
supplementation on FL (Merialdi et al., 2004); however, the quantity
of zinc used (25 mg) was more than 27 times higher than that in our
food‐based supplement (0.9 mg). An observational study in the Neth-
erlands linked higher maternal cow’s milk consumption in the first tri-
mester of pregnancy with increased fetal weight gain but found no
associations between milk consumption and fetal HC and FL (Heppe
et al., 2011). To our knowledge, there are no similar studies for GLV
and fruit.4.3 | Visit 2 biometry: interaction with maternal
parity
We found an interaction between intervention group and parity in
relation to fetal BPD and FL at visit 2 (19–21 weeks). Among primipa-
rous women, fetal size was smaller in the intervention group than in
controls, and the opposite was true among women with more than
one previous delivery. Since there were no similar interactions at visit
1 (9–12 weeks) or visit 3 (28–32 weeks), this suggests that fetal
growth was slower in the intervention group in early pregnancy
among women of lower parity, but “caught up” between visits 2
and 3, or that it was faster in early pregnancy among women of
higher parity and became slower between visits 2 and 3. The
observed effect should be interpreted with caution as it might be a
chance finding. In our study, as expected, birth weight increased with
parity, with the greatest increase in means between first and second
births (results not shown). A trial in Burkina‐Faso showed that the
effect of multiple‐micronutrient supplementation on birth measure-
ments was greater among multiparous women (Roberfroid et al.,
2008); however, no literature was found reporting such an effect
on fetal biometry.4.4 | Secondary analyses
There were sex‐related differences in CRL, HC, BPD, and AC, with
males having larger measurements than females (Table S3 andFigure S1). Similar to previous findings in high‐income countries, these
differences in HC, BPD, and AC started from early pregnancy and con-
tinued throughout gestation, while FL was similar for both sexes
throughout pregnancy (Shwarzler, Bland, Holden, Campbell, & Ville,
2004). We found moderate positive correlations between fetal ultra-
sound measures through pregnancy. Consistent with studies in other
populations (Gaillard, Steegers, de Jongste, Hofman, & Jaddoe, 2014),
the strongest correlations were found between adjacent visits, while
low correlations were observed between CRL at visit 1 (9–12 weeks)
or fetal measurements at visit 2 (19–21 weeks) and birth measure-
ments. The comparison between our population’s fetal ultrasound
measures and the international standards developed by the INTER-
GROWTH‐21st project showed that MMNP fetuses had a smaller AC
but similar HC and FL. This is consistent with previous studies examin-
ing differences in fetal growth between Indian and European popula-
tions (Kinare et al., 2010).5 | CONCLUSIONS
Overall, supplementation with foods rich in micronutrients did not
increase fetal size and growth as measured by standard ultrasound
techniques, at any stage of pregnancy, in this study. Future studies
should include measures of fetal soft tissues and incorporate fetal
biometry in the late third trimester.
ACKNOWLEDGMENTS
We thank the participants and field staff; Data Monitoring Committee
members Suhas Otiv (chair), Christopher Roberts (statistician), Armida
Fernandez, Lakshmi Lingam, and Hemu Adikari; Steering Committee
chairman Harsh Pal Singh Sachdev; and Jeya Henry (fruit‐bar develop-
ment) for their expert advice. We acknowledge the support of the
Women of India Network and Sneha‐India.
CONFLICTS OF INTEREST
The authors declare that they have no conflicts of interest.CONTRIBUTIONS
RPD, CHDF, BMM, and AAJ designed the research. CDG and CHDF
wrote the manuscript. AL, RDP, SAS, MG, HC, HS, and SHK conducted
the research. EM‐Z and CDG analysed the data. All the authors read
and approved the final manuscript.
REFERENCES
Barker, D. (1998). Mothers, babies and health in later life. Endiburgh:
Churchill Livingstone.
Bernstein, I., Goran, M., Amini, S., & Catalano, P. (1997). Differential growth
of fetal tissues during the second stage of pregnancy. American Journal
of Obstetrics and Gynecology, 176(1 Pt 1), 28–32.
Brough, L., Rees, G., Crawford, M., Morton, R., & Dorman, E. (2010).
Effect of multiple‐micronutrient supplementation on maternal nutrient
status, infant birth weight and gestational age at birth in a low‐
income, multi‐ethnic population. British Journal of Nutrition, 104(3),
437–445.
LAWANDE ET AL. 11 of 12bs_bs_bannerCetin, I., Berti, C., & Calabrese, S. (2010). Role of micronutrients in the
periconceptional period. Human Reproduction Update, 16(1), 80–95.
Chopra, H., Chheda, P., Kehoe, S., Taskar, V., Brown, N., Shivashankaran, D.,
… Fall, C. (2012). Dietary habits of female urban slum‐dwellers in Mum-
bai, India. Indian Journal of Maternal & Child Health, 14(2), 1–13.
Cole, T., & Green, P. (1992). Smoothing reference centile curves; the LMS
method and penalized likelihood. Statistics in Medicine, 11(10),
1305–1319.
Fall, C., Fisher, D., Osmond, C., & Margetts, B. (2009). Multiple micronutri-
ent supplementation during pregnancy in low‐income countries: A
meta‐analysis of effects on birth size and length of gestation. Food
and Nutrition Bulletin, 30(4 suppl), 533–546.
Fenton, T., & Sauve, R. (2007). Using the LMS method to calculate z‐scores
for the Fenton preterm infant growth chart. European Journal of Clinical
Nutrition, 61(12), 1380–1385.
Gaillard, R., Steegers, E., de Jongste, J., Hofman, A., & Jaddoe, V. (2014).
Tracking of fetal growth characteristics during different trimesters and
the risk of adverse birth outcomes. International Journal of Epidemiology,
43(4), 1140–1153.
Hadlock, F. (1990). Sonographic estimation of fetal age and weight. Radio-
logic Clinics of North America, 28(1), 39–50.
Haider, B. A., & Bhutta, Z. A. (2015). Multiple‐micronutrient supplementa-
tion for women during pregnancy. Cochrane Database of Systematic
Reviews, 11.
Heppe, D., van Dam, R., Willemsen, S., den Breeijen, H., Raat, H., Hofman,
A., … Jaddoe, V. (2011). Maternal milk consumption, fetal growth, and
the risks of neonatal complications: The Generation R Study. The
American Journal of Clinical Nutrition, 94(2), 501–509.
International Institute for Population Sciences. (2001). National Family
Health Survey (NFHS‐2), India, 1998‐99: Maharashtra. Mumbai.
Retrieved from http://dhsprogram.com/pubs/pdf/FRIND2/FRIND2.
pdf
Johnson, W., Darboe, M. K., Sosseh, F., Nshe, P., Prentice, A. M., & Moore,
S. E. (2016). Association of prenatal lipid‐based nutritional supplemen-
tation with fetal growth in rural Gambia. Maternal & Child Nutrition.
doi: 10.1111/mcn.12367
Kawai, K., Spiegelman, D., Shankar, A., & Fawzi, W. (2011). Maternal multi-
ple micronutrient supplementation and pregnancy outcomes in
developing countries: Meta‐analysis and meta‐regression. Bulletin of
the World Health Organization, 89(6), 402–411B.
Kinare, A., Chinchwadkar, M., Natekar, A., Coyaji, K., Wills, A. K., Joglekar,
C., … Fall, C. (2010). Patterns of fetal growth in a rural Indian cohort
and a comparison with a Western European population, data from the
Pune Maternal Nutrition Study. Journal of Ultrasound in Medicine,
29(2), 215–223.
Merialdi, M., Caulfield, L., Zavaleta, N., Figueroa, A., Costigan, K., Dominici,
F., & Dipietro, J. (2004). Randomized controlled trial of prenatal zinc
supplementation and fetal bone growth. The American Journal of Clinical
Nutrition, 79(5), 826–830.
O’Connor, C., Farah, N., O’Higgibs, A., Segurado, R., Fitzpatrick, C., Turner,
M., … Kennelly, M. (2013). Longitudinal measurement of fetal thigh soft
tissue parameters and its role in the prediction of birth weight. Prenatal
Diagnosis, 33(10), 945–951.
Oliver, M., Jaquiery, A., Bloomfield, F., & Harding, J. (2007). The effects of
maternal nutrition around the time of conception on the health of the
offspring. Society for Reproduction and Fertility, 64, 397–410.
Osrin, D., & De L Costello, A. (2000). Maternal nutrition and fetal growth:
Practical issues in international health. Seminars in Neonatology, 5(3),
209–219.
Osrin, D., Vaidya, A., Shrestha, Y., Baniya, R., Manandhar, D., Adhikari, R.,
… Costello, A. (2005). Effects of antenatal multiple micronutrient sup-
plementation on birthweight and gestational duration in Nepal:
Double‐blind, randomised controlled trial. Lancet, 365(9463),
955–962.Papageorghiou, A., Ohuma, E., Altman, D., Todros, T., Ismail, L., Lambert, A.,
… International Fetal and Newborn Growth Consortium for the 21st
Century (INTERGROWTH‐21st). (2014). International standards for
fetal growth based on serial ultrasound measurements: The Fetal
Growth Longitudinal Study of the INTERGROWTH‐21st Project.
Lancet, 384(9946), 869–879.
Perni, S., Chervenak, F., Kalish, R., Maghereni‐Rothe, S., Predanic, R.,
Streltzoff, J., & Skupski, D. (2004). Intraobserver and interobserver
reproducibility of fetal biometry. Ultrasound in Obstetrics & Gynecology,
24(6), 654–658.
Potdar, R., Sahariah, S., Gandhi, M., Kehoe, S., Brown, N., Sane, H., … Fall, C.
(2014). Improving women’s diet quality preconceptionally and during
gestation: Effects on birth weight and prevalence of low birth weight
—A randomized controlled efficacy trial in India (Mumbai Maternal
Nutrition Project). The American Journal of Clinical Nutrition, 100(5),
1257–1268.
Rao, S., Yajnik, C., Kanade, A., Fall, C., Margetts, B., Jackson, A., … Desai, B.
(2001). Intake of micronutrient‐rich foods in rural Indian mothers is
associated with the size of their babies at birth: Pune Maternal
Nutrition Study. Journal of Nutrition, 131(4), 1217–1224.
Rigby, R., & Stasinopoulos, D. (2005). Generalized additive models for loca-
tion, scale and shape (with discussion). Applied Statistics, 54(3),
507–554.
Roberfroid, D., Huybregts, L., Lanou, H., Henry, M., Meda, N., Menten, J., …
Group, M. S. (2008). Effects of maternal multiple micronutrient supple-
mentation on fetal growth: A double‐blind randomized controlled trial
in rural Burkina Faso. The American Journal of Clinical Nutrition, 88(5),
1330–1340.
Sarris, I., Ioannou, C., Chamberlain, P., Ohuma, E., Roseman, F., Hoch, L., …
International Fetal and Newborn Growth Consortium for the 21st Cen-
tury (INTERGROWTH‐21st). (2012). Intra‐ and interobserver variability
in fetal ultrasound measurements. Ultrasound in Obstetrics & Gynecol-
ogy, 39(3), 266–273.
Shah, P., Ohlsson, A., & Knowledge Synthesis Group on Determinants of
Low Birth Weight and Preterm Births. (2009). Effects of prenatal
multimicronutrient supplementation on pregnancy outcomes: A meta‐
analysis. Canadian Medical Association Journal, 180(12), E99–108.
Shivashankaran, D., Gurumurthy, S., Kehoe, S., Chheda, P., Margetts, B.,
Muley‐Lotankar, P., … Potdar, R. (2011). Developing micronutrient‐rich
snacks for pre‐conception and antenatal health: the Mumbai Maternal
Nutrition Project (MMNP). In L. Amoroso, & B. Thompson (Eds.), Com-
bating micronutrient deficiencies: Food‐based approaches.
(pp. 214–223). Wallingford, UK: ; Rome, Italy: Food and Agriculture
Organization of the United NationsCAB International.
Shwarzler, P., Bland, M., Holden, D., Campbell, S., & Ville, Y. (2004). Sex‐
specific antenatal reference growth charts for uncomplicated singleton
pregnancies at 15–40 weeks of gestation. Ultrasound in Obstetrics &
Gynecology, 23(1), 23–29.
Souka, A., Pilalis, A., Papastefanou, I., Kassanons, S., & Kassanons, D.
(2012). Reproducibility study of crown‐rump length and biparietal
diameter measurements in the first trimester. Prenatal Diagnosis,
32(12), 1158–1165.
Tanner, M. (1978). Foetus into man: Physical growth from conception to
maturity. London: Open Books Publishing Ltd.
UNICEF & WHO. (2004). Low birthweight: Country, regional and global esti-
mates. New York: UNICEF.
Victora, C., Adair, L., Fall, C., Hallal, P., Martorell, R., Richter, L., … Maternal
and Child Undernutrition Study Group. (2008). Maternal and child
undernutrition: consequences for adult health and human capital.
Lancet, 371(9609), 340–357.
Watkins, A., & Fleming, T. (2009). Bloastocyst environment and its influ-
ence on offspring cardiovascular health: The heart of the matter.
Journal of Anatomy, 215(1), 52–59.
Wills, A., Yajnik, C., & Kinare, A. (2010). Maternal and paternal hight and
BMI and ptterns of fetal growth: The Pune Maternal Nutrition Study.
Early Human Development, 86(9), 535–540.
12 of 12 LAWANDE ET AL.bs_bs_bannerZagré, N., Desplats, G., Adou, P., Mamadoultaibou, A., & Aguayo, V. (2007).
Prenatal multiple micronutrient supplementation has greater impact on
birthweight than supplementation with iron and folic acid: A cluster‐
randomized, double‐blind, controlled programmatic study in rural Niger.
Food and Nutrition Bulletin, 28(3), 317–327.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the
supporting information tab for this article.How to cite this article: Lawande A, Di Gravio C, Potdar RD,
et al. Effect of a micronutrient‐rich snack taken
preconceptionally and throughout pregnancy on ultrasound
measures of fetal growth: The Mumbai Maternal Nutrition Pro-
ject (MMNP). Matern Child Nutr. 2018;14:e12441. https://doi.
org/10.1111/mcn.12441
